The VENTOR Clinical Study for Cardiac Arrest

This study is testing a device called Ventor Airway System to see if it can safely and effectively help people breathe during cardiopulmonary resuscitation (CPR) or when they stop breathing. Researchers want to see if the Ventor device can deliver oxygen and help with ventilation (breathing) during the first hour after it's inserted. They are looking for about 25 adults between 18 and 75 years old who have had a non-traumatic cardiac arrest (when the heart suddenly stops beating). You cannot join if you are already on a breathing tube (endotracheal tube), have a "do not attempt resuscitation" order, or if your family objects to your participation. The current status of this study is unclear.

Study design
This is an interventional study planning to enroll 25 participants. It is designed to evaluate the Ventor device's safety and effectiveness.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main measurements for this study will be taken from the time the device is inserted through the first hour.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06759389

The VENTOR Clinical Study

Recruiting
NAAges 18–75InterventionalTreatment
CoLabs Medical
~25 participants
Updated 2025-06-11 on ClinicalTrials.gov
What's tested:Resuscitation (Ventor)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Ability to provide oxygenation during CPR
Measured over From device insertion through 1 hour.
+3 more outcomes measured
Cardiac Arrest (CA)
1 sites across 1 states
New York1
  • Jignesh Patel, M.D., M.Sc. · PRINCIPAL_INVESTIGATOR · Stony Brook University Hospital

Opens a ready-to-send draft in your own email app — review before sending.

  • Ability to provide oxygenation during CPRFrom device insertion through 1 hour.

    As measured through the monitoring of intra-arrest PaO2

  • Ability to provide ventilation during CPRFrom device insertion through 1 hour

    As measured through the monitoring of intra-arrest PaCO2

  • Ability to provide oxygenation during CPRFrom device insertion through 1 hour

    As measured through the monitoring of intra-arrest cerebral oximetry

  • Number of participants with device-related adverse eventsFrom device insertion through 3 months

    Number and rate of adverse events